The CDK inhibitor Roscovitine enhances the therapeutic efficacy of anti-PD-1 in non-small cell lung cancer.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/41561738

C Marcela Diaz-Montero; Daniel J Lindner; Elise G Holvey-Bates; George R Stark; Patricia A Rayman; Sarmishtha De; Yvonne Parker

Jan 21, 2026